Group One Trading
ORMP icon

Group One Trading’s Oramed Pharmaceuticals ORMP Stock Holding History

Group One Trading’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,200
Closed -$2.57K – 8463
2025
Q1 		$2.57K Hold
1,200
– – ﹤0.01% 6920
2024
Q4 		$2.9K Buy
+1,200
New +$2.85K ﹤0.01% 6620
2024
Q2 		– Sell
-5,000
Closed -$14.6K – 7267
2024
Q1 		$14.6K Sell
5,000
-14,100
-74% -$39.4K ﹤0.01% 5640
2023
Q4 		$44.1K Sell
19,100
-200
-1% -$427 ﹤0.01% 5168
2023
Q3 		$50.4K Buy
19,300
+13,100
+211% +$41.2K ﹤0.01% 5090
2023
Q2 		$22.2K Sell
6,200
-5,000
-45% -$16K ﹤0.01% 5925
2023
Q1 		$24.4K Sell
11,200
-15,100
-57% -$48K ﹤0.01% 5379
2022
Q4 		$316K Buy
26,300
+8,300
+46% +$64.5K ﹤0.01% 3454
2022
Q3 		$117K Sell
18,000
-900
-5% -$7.29K ﹤0.01% 4630
2022
Q2 		$87K Buy
18,900
+7,100
+60% +$37.9K ﹤0.01% 5115
2022
Q1 		$102K Buy
11,800
+5,000
+74% +$51.2K ﹤0.01% 5475
2021
Q4 		$97K Sell
6,800
-9,700
-59% -$203K ﹤0.01% 5752
2021
Q3 		$363K Buy
16,500
+13,100
+385% +$223K ﹤0.01% 4544
2021
Q2 		$45K Sell
3,400
-3,400
-50% -$38.9K ﹤0.01% 6681
2021
Q1 		$69K Buy
6,800
+5,100
+300% +$41.9K ﹤0.01% 5974
2020
Q4 		$7K Buy
+1,700
New +$5.53K ﹤0.01% 5922
2018
Q3 		– Sell
-3,100
Closed -$23K – 5501
2018
Q2 		$23K Hold
3,100
– – ﹤0.01% 4323
2018
Q1 		$20K Hold
3,100
– – ﹤0.01% 4090
2017
Q4 		$28K Hold
3,100
– – ﹤0.01% 4023
2017
Q3 		$31K Sell
3,100
-900
-23% -$7.76K ﹤0.01% 3859
2017
Q2 		$31K Hold
4,000
– – ﹤0.01% 3755
2017
Q1 		$25K Sell
4,000
-3,000
-43% -$18.7K ﹤0.01% 3782
2016
Q4 		$43K Hold
7,000
– – ﹤0.01% 3341
2016
Q3 		$51K Buy
+7,000
New +$54.4K ﹤0.01% 3345
2016
Q2 		– Sell
-400
Closed -$3K – 4849
2016
Q1 		$3K Sell
400
-1,000
-71% -$6.7K ﹤0.01% 4312
2015
Q4 		$12K Buy
+1,400
New +$10.6K ﹤0.01% 4118
2015
Q3 		– Sell
-2,200
Closed -$12K – 5098
2015
Q2 		$12K Hold
2,200
– – ﹤0.01% 4237
2015
Q1 		$14K Buy
2,200
+1,500
+214% +$7.24K ﹤0.01% 4039
2014
Q4 		$3K Sell
700
-2,500
-78% -$16.4K ﹤0.01% 4614
2014
Q3 		$26K Sell
3,200
-2,200
-41% -$19.6K ﹤0.01% 3966
2014
Q2 		$52K Sell
5,400
-1,800
-25% -$18.4K ﹤0.01% 3519
2014
Q1 		$84K Buy
+7,200
New +$122K ﹤0.01% 3222

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Group One Trading's ORMP Position: Q2 2025 in Review

Group One Trading sold out of Oramed Pharmaceuticals (ORMP) in Q2 2025, closing a stake of 3,310 shares — an estimated $7.3K sold.

Group One Trading first reported a position in ORMP in Q1 2014 and held it in 29 quarters. The position peaked at $1.23M in Q4 2022. 47 funds tracked by Wall St. Rank hold ORMP as of Q2 2025.

  • Group One Trading reported no remaining Oramed Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 3,310 Oramed Pharmaceuticals shares in Q2 2025, an estimated $7.3K.
  • Group One Trading first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 29 quarters.
  • Group One Trading's Oramed Pharmaceuticals position peaked at $1.23M in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.